Editorial
The challenges and opportunities for the management of rheumatoid arthritis in China: an annual report of 2019
Tian Xinping, Li Mengtao, Zeng Xiaofeng
Published 2021-07-01
Cite as Chin J Intern Med, 2021, 60(7): 593-598. DOI: 10.3760/cma.j.cn112138-20210207-00113
Contributor Information
Tian Xinping
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology,State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Li Mengtao
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology,State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Zeng Xiaofeng
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology,State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China